Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Thomas Reynaud
Observed names:
Reynaud, Thomas,
T Reynaud,
T. Reynaud
Institution:
Centre Hospitalier Universitaire de Saint-Étienne
Observed institutions:
Centre Georges François Leclerc,
University Hospital of Geneva,
Pitié-Salpêtrière Hospital,
Centre Hospitalier Universitaire de Saint-Étienne,
Centre de recherche du CHU de Québec-Université Laval,
CHU de Québec-Université Laval
show all 6
ORCID:
0000-0002-4376-0697
Observed ORCID:
0000-0002-4376-0697
OpenAlex ID:
A5020794024
Patient and procedural features predicting early and mid-term outcome after radical surgery for non-small cell lung cancer
2018
·
Christoph Ellenberger
, Najia Garofano
, et al.
·
Journal of Thoracic Disease
·
24
PDF
PSA outcomes and late toxicity of single-fraction HDR brachytherapy and LDR brachytherapy as monotherapy in localized prostate cancer: A phase 2 randomized pilot study
2021
·
Thomas Reynaud
, Lara Hathout
, et al.
·
Brachytherapy
·
15
Pretreatment with glucose–insulin–potassium improves ventricular performances after coronary artery bypass surgery: a randomized controlled trial
2019
·
Marc Licker
, Thomas Reynaud
, et al.
·
Journal of Clinical Monitoring and Computing
·
14
PDF
Hypofractionated Stereotactic Radiotherapy as a Salvage Therapy for Recurrent High-Grade Gliomas: Single-Center Experience
2018
·
Thomas Reynaud
, Aurélie Bertaut
, et al.
·
Technology in Cancer Research & Treatment
·
13
Determinants of hospital length of stay after transcatheter aortic valve implantation with self-expanding prostheses: a prospective, single centre observational study
2019
·
Angela Frei
, Dionysios Adamopoulos
, et al.
·
Swiss Medical Weekly
·
11
PDF
Efficacy and safety of glycoprotein IIb/IIIa receptor antagonists for patients undergoing percutaneous coronary intervention within twelve hours of fibrinolysis
2011
·
Loic Belle
, Magali Fourny
, et al.
·
Catheterization and Cardiovascular Interventions
·
11
Phase 2, multicenter, randomized study of salvage radiation therapy +/- metformin for recurrent prostate cancer after radical prostatectomy (SAKK 08/15 – GETUG-AFU 34 PROMET trial).
2023
·
Alan Dal Pra
, Stephane Supiot
, et al.
·
Journal of Clinical Oncology
·
4
Immunogenicity of radiotherapy on bone metastases from prostate adenocarcinoma: What is the future for the combination with radiotherapy/immunotherapy?
2024
·
Pierre Cornillon
, Wafa Bouleftour
, et al.
·
Tumori Journal
·
3
Infection after prostatic transrectal fiducial marker implantation for image guided radiation therapy
2023
·
T. Reynaud
, I. Ben Aicha
, et al.
·
Cancer/Radiothérapie
·
3
Radiotherapy with twice weekly Gemcitabine and Cisplatin compared to Cisplatin alone for organ preservation in muscle-invasive bladder cancer: results of the GETUG V04 randomized phase II trial
2026
·
Morgan Michalet
, Philippe Ronchin
, et al.
·
Radiotherapy and Oncology
·
2
11 / Pretreatment with glucose-insulin-potassium improves ventricular performances after on-pump coronary artery bypass surgery: a randomized controlled trial
2018
·
Thomas Reynaud
·
1
EP-1164: Bone and dental complications in patients with head and neck cancer treated with IMRT
2018
·
T. Reynaud
, A. Bertaut
, et al.
·
Radiotherapy and Oncology
·
1
PDF
Long-term Oncologic Outcomes of a Phase 2 Randomized Pilot Study Comparing Low Dose Rate Brachytherapy and High Dose Rate Brachytherapy as Monotherapy in Localized Prostate Cancer
2026
·
Damien Carignan
, Thomas Reynaud
, et al.
·
Radiotherapy and Oncology
Prospective Evaluation of Efficacy and Toxicity of Focal Salvage High-dose-rate Brachytherapy for Locally Recurrent Prostate Cancer After Definitive Radiation Therapy
2026
·
Thomas Reynaud
, Damien Carignan
, et al.
·
Radiotherapy and Oncology
Implementation of a 1.5t Mr-linac: Initial Clinical Experience and Longitudinal Impact on Staff and Patient Quality of Life
2026
·
Thomas Reynaud
, François Fabi
, et al.
·
Radiotherapy and Oncology
4025 ETADAPT: a randomised, multicentre, phase 3 trial to assess the effectiveness of therapeutic education on reproducibility for prostate radiotherapy
2026
·
Pascale Roux
, Sophie Boisbouvier
, et al.
·
Radiotherapy and Oncology
4932 A prospective abdominal SBRT treatment study using exhale gating combined with optimized margin and Comprehensive Motion Management
2026
·
Eric Poulin
, Thomas Reynaud
, et al.
·
Radiotherapy and Oncology
1674 Standardized optimization to improve workflow efficiency and dosimetric robustness in magnetic resonance guided adaptive radiotherapy (MRgART)
2026
·
Raphael Mathieu
, Bernard Lachance
, et al.
·
Radiotherapy and Oncology
2435 The Human Dimensions of MR-LINAC Integration: Early Insights from a Longitudinal Evaluation of Staff and Patient Quality of Life
2026
·
Francois Fabi
, Damien Carignan
, et al.
·
Radiotherapy and Oncology
1674 Standardized optimization to improve workflow efficiency and dosimetric robustness in magnetic resonance guided adaptive radiotherapy (MRgART)
2026
·
Raphael Mathieu
, Bernard Lachance
, et al.
·
Radiotherapy and Oncology
2517TiP Combination of darolutamide and stereotactic body radiation therapy in patients with castration resistant prostate cancer (CRPC) and oligometastases on functional imaging (GETUG-AFU 43–PEACE8)
2025
·
R. Flippot
, S. Foulon
, et al.
·
Annals of Oncology
725 Concurrent chemoradiotherapy with Cisplatin and Gemcitabine in muscle-invasive bladder cancer: results of a prospective phase II trial (NCT01495676)
2025
·
Morgan Michalet
, Philippe Ronchin
, et al.
·
Radiotherapy and Oncology
34: Infectious Risk After Prostatic Transrectal Fiducial Marker Implantation in Radiation Therapy
2021
·
Thomas Reynaud
, Ibtihel Ben Aicha
, et al.
·
Radiotherapy and Oncology
PO-1320 Infectious Risk After Prostatic Transrectal Fiducial Marker Implantation in Radiation Therapy
2021
·
T. Reynaud
, I. Ben Aicha
, et al.
·
Radiotherapy and Oncology
PP-0156 HDR and LDR comparison as monotherapy in localized prostate cancer: PSA kinetic and late toxicity
2021
·
T. Reynaud
, L. Hathout
, et al.
·
Radiotherapy and Oncology
Show more works
View as search
Works count:
32
Citation count:
102
H-index:
6
I10-index:
6
Year
Topic
Type